Low-dose Fosphenytoin for Aborting Acute Trigeminal Neuralgia Pain: A Case Report
Introduction: While the typical treatment for trigeminal neuralgia is carbamazepine, the dose must be gradually titrated over time to achieve pain control, which makes the drug a less than ideal candidate for treatment for acute exacerbation of pain due to trigeminal neuralgia in the emergency depar...
Saved in:
Published in: | Clinical practice and cases in emergency medicine Vol. 7; no. 3; pp. 182 - 184 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
01-08-2023
eScholarship Publishing, University of California |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Introduction: While the typical treatment for trigeminal neuralgia is carbamazepine, the dose must be gradually titrated over time to achieve pain control, which makes the drug a less than ideal candidate for treatment for acute exacerbation of pain due to trigeminal neuralgia in the emergency department (ED) setting. The literature for other effective treatments for acute exacerbations of trigeminal neuralgia is currently lacking. We discuss a case where intravenous (IV) fosphenytoin was used for treatment of acute pain due to trigeminal neuralgia in the ED. Case Report: This is a case of a 35-year-old male diagnosed with trigeminal neuralgia who presented with acute facial pain. His history and physical exam were consistent with an acute exacerbation of his trigeminal neuralgia. The patient was refractory to multiple doses of standard pain medication in the ED, and the decision was made to attempt IV fosphenytoin to relieve his pain. He was given 250 milligrams of fosphenytoin that was infused via IV over 10 minutes. By the end of the infusion, the patient had reported complete resolution of his pain.Conclusion: Fosphenytoin is a viable treatment option for pain relief in patients with acute exacerbation of trigeminal neuralgia. It may be a more favorable drug to use in the ED for acute pain given that carbamazepine must be titrated to effect. It is also possible that lower doses of fosphenytoin may provide equally beneficial analgesic effect than what is described in the literature, as pain relief was achieved in our case with approximately 3 milligrams/kilogram of fosphenytoin. |
---|---|
AbstractList | INTRODUCTIONWhile the typical treatment for trigeminal neuralgia is carbamazepine, the dose must be gradually titrated over time to achieve pain control, which makes the drug a less than ideal candidate for treatment for acute exacerbation of pain due to trigeminal neuralgia in the emergency department (ED) setting. The literature for other effective treatments for acute exacerbations of trigeminal neuralgia is currently lacking. We discuss a case where intravenous (IV) fosphenytoin was used for treatment of acute pain due to trigeminal neuralgia in the ED. CASE REPORTThis is a case of a 35-year-old male diagnosed with trigeminal neuralgia who presented with acute facial pain. His history and physical exam were consistent with an acute exacerbation of his trigeminal neuralgia. The patient was refractory to multiple doses of standard pain medication in the ED, and the decision was made to attempt IV fosphenytoin to relieve his pain. He was given 250 milligrams of fosphenytoin that was infused via IV over 10 minutes. By the end of the infusion, the patient had reported complete resolution of his pain. CONCLUSIONFosphenytoin is a viable treatment option for pain relief in patients with acute exacerbation of trigeminal neuralgia. It may be a more favorable drug to use in the ED for acute pain given that carbamazepine must be titrated to effect. It is also possible that lower doses of fosphenytoin may provide equally beneficial analgesic effect than what is described in the literature, as pain relief was achieved in our case with approximately 3 milligrams/kilogram of fosphenytoin. Introduction: While the typical treatment for trigeminal neuralgia is carbamazepine, the dose must be gradually titrated over time to achieve pain control, which makes the drug a less than ideal candidate for treatment for acute exacerbation of pain due to trigeminal neuralgia in the emergency department (ED) setting. The literature for other effective treatments for acute exacerbations of trigeminal neuralgia is currently lacking. We discuss a case where intravenous (IV) fosphenytoin was used for treatment of acute pain due to trigeminal neuralgia in the ED. Case Report: This is a case of a 35-year-old male diagnosed with trigeminal neuralgia who presented with acute facial pain. His history and physical exam were consistent with an acute exacerbation of his trigeminal neuralgia. The patient was refractory to multiple doses of standard pain medication in the ED, and the decision was made to attempt IV fosphenytoin to relieve his pain. He was given 250 milligrams of fosphenytoin that was infused via IV over 10 minutes. By the end of the infusion, the patient had reported complete resolution of his pain. Conclusion: Fosphenytoin is a viable treatment option for pain relief in patients with acute exacerbation of trigeminal neuralgia. It may be a more favorable drug to use in the ED for acute pain given that carbamazepine must be titrated to effect. It is also possible that lower doses of fosphenytoin may provide equally beneficial analgesic effect than what is described in the literature, as pain relief was achieved in our case with approximately 3 milligrams/kilogram of fosphenytoin. |
Author | Lin, Alexander Baydoun, Jamie Miya, Jared |
AuthorAffiliation | University Medical Center of Southern Nevada, Department of Psychiatry and Behavioral Health, Las Vegas, Nevada University of Nevada Las Vegas School of Medicine, Department of Emergency Medicine, Las Vegas, Nevada Sound Emergency Physicians, Department of Emergency Medicine, Las Vegas, Nevada |
AuthorAffiliation_xml | – name: University Medical Center of Southern Nevada, Department of Psychiatry and Behavioral Health, Las Vegas, Nevada – name: University of Nevada Las Vegas School of Medicine, Department of Emergency Medicine, Las Vegas, Nevada – name: Sound Emergency Physicians, Department of Emergency Medicine, Las Vegas, Nevada |
Author_xml | – sequence: 1 givenname: Jamie surname: Baydoun fullname: Baydoun, Jamie – sequence: 2 givenname: Alexander surname: Lin fullname: Lin, Alexander – sequence: 3 givenname: Jared surname: Miya fullname: Miya, Jared |
BookMark | eNpVkVFrHCEUhaWkNGmal_4CH0thUh111L6UZUjawDZJSwp9kzuOMzHM6lZnWvLv62ZDSEC4cu_xO1fOW3QQYnAIvafkVChKP7XX7dn3U9oQ9god1Vzyqhb174Nn90N0kvMdIYQqRWWj3qBDJoUWjIoj9GMd_1V9zA6fx7y9deF-jj7gISa86mKafRjxyi6zwzfJj27jA0z40i0JptEDvgYfPuMVbqEQfrptefEOvR5gyu7ksR6jX-dnN-23an319aJdrStb64ZVtpG0H5ggmllCuaA9EKgVJ2ywinJKdM2Ag5BW2qbvWNcpy63ry-GcQ8OO0cWe20e4M9vkN5DuTQRvHhoxjQbK_nZyRgkhoQPbUVmQtSz-PUjZycIXje4L68uetV26zc4jzOWDL6AvJ8HfmjH-NZRwpjQXhfDhkZDin8Xl2Wx8tm6aILi4ZFMrwTRnutFF-nEvtSnmnNzw5EOJ2WVqHjI1u0zZfzelk84 |
ContentType | Journal Article |
Copyright | 2023 Baydou et al. 2023 |
Copyright_xml | – notice: 2023 Baydou et al. 2023 |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.5811/CPCEM.1603 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 2474-252X |
EndPage | 184 |
ExternalDocumentID | oai_doaj_org_article_8557abacb17a4a27963da77b74a5569d 10_5811_CPCEM_1603 |
GroupedDBID | 7X7 8FI 8FJ AAYXX ABUWG ADBBV AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS AUK BCNDV BENPR CCPQU CITATION FYUFA GROUPED_DOAJ HMCUK HYE M~E OK1 PGMZT PIMPY PQQKQ PROAC RPM UKHRP 7X8 5PM |
ID | FETCH-LOGICAL-c2963-c671df35093c01451da0a28403fc81410923a4a57c7c6db3bb8c4cedced444a63 |
IEDL.DBID | RPM |
ISSN | 2474-252X |
IngestDate | Tue Oct 22 15:12:43 EDT 2024 Tue Sep 17 21:29:49 EDT 2024 Fri Aug 16 01:09:17 EDT 2024 Thu Nov 21 22:23:09 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2963-c671df35093c01451da0a28403fc81410923a4a57c7c6db3bb8c4cedced444a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438945/ |
PMID | 37595315 |
PQID | 2853943969 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8557abacb17a4a27963da77b74a5569d pubmedcentral_primary_oai_pubmedcentral_nih_gov_10438945 proquest_miscellaneous_2853943969 crossref_primary_10_5811_CPCEM_1603 |
PublicationCentury | 2000 |
PublicationDate | 20230801 |
PublicationDateYYYYMMDD | 2023-08-01 |
PublicationDate_xml | – month: 08 year: 2023 text: 20230801 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Clinical practice and cases in emergency medicine |
PublicationYear | 2023 |
Publisher | University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine eScholarship Publishing, University of California |
Publisher_xml | – name: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine – name: eScholarship Publishing, University of California |
SSID | ssj0001881768 |
Score | 2.2791843 |
Snippet | Introduction: While the typical treatment for trigeminal neuralgia is carbamazepine, the dose must be gradually titrated over time to achieve pain control,... INTRODUCTIONWhile the typical treatment for trigeminal neuralgia is carbamazepine, the dose must be gradually titrated over time to achieve pain control, which... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 182 |
SubjectTerms | Case Report |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELaACQkhnqK8ZASrRePYscNWSqsOgIoAiS1ybBcqQVLRVoh_z51dEJlYWPPOnZPvu_P5O0LORjwZAaxJ5gHNmHDGsjITOXPC5ACYqu0d5jsG9-r2SV_1UCbnp9UX1oRFeeBouHMtpTKlsWWijDBcwYBxRqlSCSNllrvw921nv4KpkF3ROlFhHRwXSjAu-VPUJpU6Sc7txPo3zKukDTQKov0Nptmsk_wFPP0Nsr5gjLQTn3STLPlqi6zFdBuNq4i2yd11_cFcPfW0X0-xbOtzVo8rCoyUYvMrrG2mHTufefoA4bgPnbwoCnOY1-exoUMzri5oh3YB02jk5Dvksd976A7YolsCsxyMwmymEjdKgQCkNvTfdaZtAHza6chqrOYEKgcWlMoqm7kyLUtthcWXc0IIk6W7ZKWqK79HqLbwoVoO15NKCFtq77lRcEKapBkEVC1y-m21YhJFMQoIJtC2RXfY7d0UaNsWuUSD_hyBQtZhA7i3WLi3-Mu9LXLy7Y4CBj7OZpjK1_NpwYFo5ECnsrxFdMNPjTs291TjlyChneAEaC7k_n884wFZxSb0sSzwkKzM3uf-iCxP3fw4jMovEPDmXQ priority: 102 providerName: Directory of Open Access Journals |
Title | Low-dose Fosphenytoin for Aborting Acute Trigeminal Neuralgia Pain: A Case Report |
URI | https://search.proquest.com/docview/2853943969 https://pubmed.ncbi.nlm.nih.gov/PMC10438945 https://doaj.org/article/8557abacb17a4a27963da77b74a5569d |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED6tPE2aprGBVgbI0_Ya2iR27PBWQisextRpIPEW2WeXRaJJRVsh_nvOToPI616TOPGPi77vzp_vAH4uknhBsCYiR2gWcasxMhnPI8t1ToApx876eMfVX_n7Tl1OfZqcrDsLE0T7aKqz-mF5Vlf_grZytcRRpxMbza-L2G9f5VyMBjAgcvjGRw-RFaViItFtLlKh4niEK3RLH0fxVXNSKXIyPNEDopCvv0cy-xLJN5gz-wQfd2SRTdpO7cM7V3-GD22kjbUHiL7An1_NU2SbtWOzZu0VW8-bpqoZkVHm6155WTOb4Hbj2A154i4U8WI-J4d-uK80m-uqPmcTVhCcsZaOH8DtbHpTXEW7QgkRJvQDRZjJ2C5Swv4UQ-ldq8eacGecLlB5ISexOM21kCgxsyY1RiFHPzjLOddZegh7dVO7r8AU0j-KCb1PSM7RKOcSLalBGqcZ-VJD-NHNWrlq82GU5Ef4aS6LeTG9Lv00D-HCT-jrEz6HdbjQPN6Xu5UslRBSG40mltS5RNJIrJbSSOqpyHI7hO_dcpRk834jQ9eu2a7LhDhGTkwqy4egeuvU-2L_DhlTyJ7dGc_R_zf9Bu991flWB3gMe5vHrTuBwdpuT4NPfxoM8gUXJeYW |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-x8QAS4nuiwIYRvGbNhx07vHVZqyLaqYgi8Wb5qyPSmlRrK8R_z9lp0PK61zhObJ9P97vzz3cAn1dpskKzxiKH1iyiVplI57SILFUFGkweO-vjHdMf_OqXuBz7NDl5dxcmkPaNrs7rm_V5Xf0O3MrN2gw7nthwMS8Tf3xVUDY8goeosHF8x0sPsRUhEoTRbTZSJpJkaDbGrX0kxdfNyTgrcOuxnikKGft7MLNPkrxjdSbP7jve5_D0gDPJqG1_AQ9c_RKetEE60t49egXfZ82fyDZbRybN1pO9_u6aqiaIY4kvmeUZ0WRk9jtHlujEu1D_i_h0HurmulJkoar6CxmREi0haZH8a_g5GS_LaXSosRCZFHUvMjlP7CpD2JCZULXXqlihyYqzlRGeA4oAUFHFuOEmtzrTWhhq_KpYSqnKsxM4rpvavQEiDKq3SfF7jFNqtHAuVRw7ZEmWoxs2gE_dcstNm0pDogvi5SPLRTmeSy-fAVx4Sfx_w6e_Dg-a22t5WFQpGONKK6MTjoNLOc7EKs41x5GyvLAD-NjJUaK6-DMQVbtmv5UpwpMCQVheDED0BNz7Y78F5RoSb3dyfHv_rh_g0XQ5n8nZ16tv7-CxL17f0gnfw_Hudu9O4Whr92dhP_8D9dr63A |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xISGkifE10cHACF6zNIkdO3vrslZDbFMRQ-LN8ldGpDWp1laI_56z06Dllb0mdmL7fLrfnX--A_hcpUmFZo1FDq1ZRK0ykc5pEVmqCjSYfOysj3ecf-dXP8XZ1KfJOenvwgTSvtH1cXO7OG7qX4FbuVyYuOeJxfPLMvHHVwVl8dJW8Q48RqUdp_c89RBfESJBKN1lJGUiSWKzNG7hoym-dk7GWYHbjw3MUcjaP4CaQ6LkPcsz23_ImJ_Dsy3eJJOuzQt45JqXsNcF60h3B-kVfLtof0e2XTkya1ee9PVn3dYNQTxLfOksz4wmE7NZO3KNzrwLdcCIT-uhbm9qReaqbk7IhJRoEUmH6F_Dj9n0ujyPtrUWIpOiDkYm54mtMoQPmQnVe60aKzRd46wywnNBEQgqqhg33ORWZ1oLQ41fGUspVXl2ALtN27g3QIRBNTcpfo9xSo0WzqWKY4csyXJ0x0bwqV9yuexSakh0RbyMZDkvp5fSy2gEp14a_1r4NNjhQXt3I7cLKwVjXGlldMJxcCnHmVjFueY4UpYXdgQfe1lKVBt_FqIa125WMkWYUiAYy4sRiIGQB38cvkHZhgTcvSwP_7_rB3gyP5vJiy9XX9_CU1_DvmMVvoPd9d3GHcHOym7ehy39F-RD_Vw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low-dose+Fosphenytoin+for+Aborting+Acute+Trigeminal+Neuralgia+Pain%3A+A+Case+Report&rft.jtitle=Clinical+practice+and+cases+in+emergency+medicine&rft.au=Baydoun%2C+Jamie&rft.au=Lin%2C+Alexander&rft.au=Miya%2C+Jared&rft.date=2023-08-01&rft.eissn=2474-252X&rft.volume=7&rft.issue=3&rft.spage=182&rft.epage=184&rft_id=info:doi/10.5811%2Fcpcem.1603&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2474-252X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2474-252X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2474-252X&client=summon |